- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/433 - Thiadiazoles
Patent holdings for IPC class A61K 31/433
Total number of patents in this class: 1692
10-year publication summary
|
98
|
123
|
104
|
82
|
95
|
89
|
96
|
95
|
121
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4793 |
37 |
| Novartis AG | 10463 |
18 |
| The Regents of the University of California | 20447 |
17 |
| Merck Sharp & Dohme LLC | 3719 |
17 |
| Takeda Pharmaceutical Company Limited | 2722 |
15 |
| Betagenon AB | 23 |
15 |
| Universite de Montreal | 342 |
15 |
| Board of Regents, The University of Texas System | 6028 |
14 |
| Abbvie Inc. | 1832 |
13 |
| Calithera Biosciences, Inc. | 38 |
12 |
| Proteostasis Therapeutics, Inc. | 68 |
12 |
| Boehringer Ingelheim International GmbH | 4576 |
11 |
| The Trustees of the University of Pennsylvania | 4396 |
11 |
| Array BioPharma Inc. | 468 |
11 |
| Ovid Therapeutics Inc | 170 |
11 |
| Shionogi & Co., Ltd. | 833 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2958 |
11 |
| The Wistar Institute of Anatomy and Biology | 468 |
11 |
| Calico Life Sciences LLC | 104 |
11 |
| Hoffmann-La Roche Inc. | 3640 |
10 |
| Other owners | 1409 |